×

What are you searching for?




Healthcare

4 Min read

Examination of the outcomes of BioCryst Pharmaceuticals Inc. (BCRX) and Seattle Genetics Inc. (NASDAQ: SGEN)

Published On 19 Dec 2019 07:59 AM


SHARE THIS ARTICLE  


In the biotechnology sector, BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) and Seattle Genetics Inc. (NASDAQ: SGEN) are competing with each other. We will compare them and contrast their profitability, recommendations for analysts, risk, ownership of institutions, dividends, earnings, and valuation.

A 2.05 alpha Volatility & Risk suggests that BioCryst Pharmaceuticals Inc. is 105.00 times more volatile than Standard and Poor's....


Tags : biotechnology ,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)